🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05733208
Active, not recruiting Not applicable

The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery

NCT05733208 · tracked via the Priya Life Science China tracker
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Phase
Not applicable
Started
2023-05-06
Last updated
2026-04-22

Condition(s) studied

Myocardial InjuryNon-cardiac SurgeryRemote Ischemic Preconditioning

Investigational drug(s) / intervention(s)

Remote ischemic preconditioningSham-remote ischemic preconditioning

Remote ischemic preconditioning: Remote ischemic preconditioning will consist of four cycles of 5-minute inflation of an blood pressure cuff on the upper arm to 200 mmHg followed by 5-minute deflation. RIPC will be performed twice, one at approximately 24 hours before anaesthesia and the other at approximately 1 hour before anaesthesia.

Sham-remote ischemic preconditioning: The identical looking cuff will be placed around the upper arm but not actually inflated for 40 minutes. The control device's components and external appearance are identical to that of the RIPC. However, as compared to the RIPC, the blood pressure cuff's line of inflation is disconnected such that the cuff cannot be inflated. Control treatment will be performed twice, one at approximately 24 hours before anaesthesia and the other at approximately 1 hour before anaesthesia.

Study summary

This is a multicentre, parallel-group, randomised, sham-controlled, observer blinded trial, assessing the efficacy of remote ischemic preconditioning on preventing myocardial injury after noncardiac surgery.

Eligibility

Sex
ALL
Min age
45 Years
Max age
Healthy volunteers
No
Inclusion criteria 1. Patients at high clinical risk for cardiovascular events; 2. Patients scheduled to undergo major abdominal surgery. Exclusion criteria 1. Immediate or urgent surgery or surgery where there is insufficient time to perform RIPC. 2. Abdominal vascular surgery, such as surgery for abdominal aortic aneurysm 3. Experience of conditions precluding the use of RIPC in both arms 4. Patients who are being treated with drugs, such as sulphonamide or nicorandil 5. With contraindications for anaesthetic regimes required in this trial.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou Guangdong

More Sixth Affiliated Hospital, Sun Yat-sen University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05733208 on ClinicalTrials.gov ↗ ← All trials in China